Experimental design towards an optimal lipid nanosystem: A new opportunity for paclitaxel-based therapeutics

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 2, 2013, Pages 302-310

  Videira, Mafalda A ^a   Arranja, Alexandra G ^a   Gouveia, Luís F ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

Emulsification solidification; Paclitaxel; Solid lipid nanoparticles (SLNs)

Indexed keywords

DRUG CARRIER; PACLITAXEL; SOLID LIPID NANOPARTICLE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; EMULSION; HOMOGENIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; DIGLYCERIDES; FATTY ACIDS; MICE; NANOPARTICLES; PACLITAXEL;

EID: 84877054295     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.03.005     Document Type: Article

References (48)

1. I. Ali, Rahis-Uddin, K. Salim, M.A. Rather, W.A. Wani, and A Haque Advances in Nano Drugs for Cancer Chemotherapy Curr. Cancer Drug Targets 11 2011 135 146
2. P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci, and C. Rossi Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Deliv. Rev. 59 2007 454 477
3. K. Bouchemal, S. Briancon, E. Perrier, and H. Fessi Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation Int. J. Pharm. 280 2004 241 251
4. L. Brannon-Peppas, and J.O. Blanchette Nanoparticle and targeted systems for cancer therapy Adv. Drug Deliv. Rev. 56 2004 1649 1659
5. H. Bunjes, and B. Siekmann Manufacture, characterization, and applications of solid lipid nanoparticles as drug delivery systems S. Benita, Microencapsulation: Methods and Industrial Implications second ed. 2006 Taylor and Francis New York 213 268
6. H. Bunjes, and T. Unruh Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering Adv. Drug Deliv. Rev. 59 2007 379 402
7. R. Cavalli, O. Caputo, and M.R. Gasco Preparation and characterization of solid lipid nanospheres containing paclitaxel Eur. J. Pharm. Sci. 10 2000 305 309
8. S.S. Chakravarthi, S. De, D.W. Miller, and D.H. Robinson Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles Int. J. Pharm. 383 2010 37 44
9. P. Couvreur, and C. Vauthier Nanotechnology: intelligent design to treat complex disease Pharm. Res. 23 2006 1417 1450
10. S.J. Douglas, S.S. Davis, and L. Illum Nanoparticles in drug delivery Crit. Rev. Ther. Drug Carrier Syst. 3 3 1987 233 261
11. European Pharmacopoeia, 2011. 2.6.1. Sterility, seventh ed.; The Council of Europe.
12. S. François, and F. Hatem Industrial technologies and scale up S. Benita, Microencapsulation: Methods and Industrial Implications second ed. 2006 Taylor and Francis New York 149 182
13. P. Giannakakou, R. Robey, T. Fojo, and M. Blagosklonny Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity Oncogene 20 2001 3806 3813
14. M.R. Green Abraxane(R) a novel Cremophor(R)-free albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer Ann. Oncol. 17 2006 1263 1268
15. K.L. Hennenfent, and R. Govindan Novel formulations of taxanes: a review. Old wine in a new bottle? Ann. Oncol. 17 2006 735 749
16. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
17. D. Hou, C. Xie, K. Huang, and C. Zhu The production and characteristics of solid lipid nanoparticles (SLNs) Biomaterials 24 2003 1781 1785
18. N. Ibrahim, N. Desai, S. Legha, P. Soon-Shiong, R. Theriault, E. Rivera, B. Esmaeli, S. Ring, A. Bedikian, G. Hortobagyi, and J. Ellerhorst Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel Clin. Cancer Res. 8 2002 1038 1044
19. M.D. Joshi, and R.H. Müller Lipid nanoparticles for parenteral delivery of actives Eur. J. Pharm. Biopharm. 71 2009 161 172
20. S. Kamboj, S. Bala, and A.B. Nair Solid lipid nanoparticles: an effective lipid based technology for poorly water soluble drugs Int. J. Pharm. Sci. Rev. Res. 5 2010 78 90
21. E.S. Kawasaki, and A. Player Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer Nanomedicine 1 2005 101 109
22. I. Kuppens Current state of the art of new tubulin inhibitors in the clinic Curr. Clin. Pharmacol. 1 2006 57 70
23. M. Lee, S. Lim, and C. Kim Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles Biomaterials 28 2007 2137 2146
24. R. Li, J.S. Eun, and M.-K. Lee Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration Arch. Pharm. Res. 34 2011 331 337
25. S. Martins, S. Costa-Lima, T. Carneiro, A. Cordeiro-da-Silva, E.B. Souto, and D.C. Ferreira Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway Int. J. Pharm. 430 2012 216 227
26. W. Mehnert, and K. Mader Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
27. A. Miglietta, R. Cavalli, C. Bocca, L. Gabriel, and M.R. Gasco Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel Int. J. Pharm. 210 2000 61 67
28. S.M. Moghimi Nanomedicine: current status and future prospects FASEB J. 19 2005 311 330
29. A. Moreno-Aspitia, and E.A. Perez Nanoparticle albumin-bound paclitaxel (ABI-007): a newer taxane alternative in breast cancer Future Oncol. 1 2005 755 762
30. R.H. Müller, W. Mehnert, J.S. Lucks, C. Schwarz, A. zur Mühlen, H. Weyhers, C. Freitas, and D. Rühl Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery Eur. J. Pharm. Biopharm. 41 1 1995 62 69
31. R. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
32. B. Nuijen, M. Bouma, J.H.M. Schellens, and J.H. Beijnen Progress in the development of alternative pharmaceutical formulations of taxanes Invest. New Drugs 19 2001 143 153
33. N. Portney, and M. Ozkan Nano-oncology: drug delivery, imaging, and sensing Anal. Bioanal. Chem. 384 2006 620 630
34. R. Reul, T. Renette, N. Bege, and T. Kissel Nanoparticles for paclitaxel delivery: a comparative study of different types of dendritic polyesters and their degradation behavior Int. J. Pharm. 407 2011 190 196
35. R.R. Sawant, and V. Torchilin Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo Int. J. Pharm. 374 2009 114 118
36. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
37. S. Sun, J.H. Schiller, M. Spinola, and J.D. Minna New molecularly targeted therapies for lung cancer J. Clin. Invest. 117 2007 2740 2750
38. V.P. Torchilin Multifunctional Nanocarriers Adv. Drug Deliv. Rev. 58 14 2006 1532 1555
39. V. Venkateswarlu, and K. Manjunath Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles J. Controlled Release 95 2004 627 638
40. Videira, M.; 2008. Nanopartículas Lipídicas como sistemas transportadores de fármacos para administração pulmonar, PhD Thesis, University of Lisbon (Faculty of Pharmacy).
41. Videira, M.; Almeida, A.; 1998. Can solid lipid nanoparticles be produced by a simple emulsion/solidification technique? In: Proceedings III Spanish-Portuguese Conference on Controlled Drug Delivery. Lisbon, 125-126.
42. M. Videira, M. Botelho, A. Santos, L. Gouveia, J.d. Lima, and A. Almeida Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles J. Drug Target. 10 2002 607 613
43. K. Westesen Novel lipid-based colloidal dispersions as potential drug administration systems - expectations and reality Colloid Polym. Sci. 278 2000 608 618
44. S.A. Wissing, O. Kayser, and R. Müller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272
45. H. Wong, R. Bendayan, A. Rauth, Y. Li, and X. Wu Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 491 504
46. D. Yang, L. Yu, and S. Van Clinically relevant anticancer polymer paclitaxel therapeutics Cancers 3 2010 17 42
47. D.H. Young, E.L. Michelotti, C.S. Swindell, and N.E. Krauss Antifungal properties of taxol and various analogues Experientia 48 1992 882 885
48. H. Yuan, J. Miao, Y. Du, J. You, F. Hu, and S. Zeng Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells Int. J. Pharm. 348 2008 137 145